Search

You searched for "outpatient"

598 results found

Adjuvant radiotherapy versus wait-and-see after radical prostatectomy

1 September 2014 | | URO - Urologic Oncology
Optimum treatment modalities in prostate cancer continue to evolve, with debates at each stage of the evolution process, from focal therapy to radical treatment. In this randomised study, Wiegel et al. investigated the role of adjuvant radiotherapy following open radical...

Comparison of PCNL under spinal versus general anaesthesia

1 May 2014 | | URO - Endourology & Stones
There are several advantages of performing percutaneous nephrolithotomy (PCNL) under spinal anaesthesia including lower cost, reduced adverse effects and less tracheal tube displacement. Another advantage is that the patient remains awake throughout making positioning easier and reducing the risk of...

A phase II dose-ranging study of mirabegron in patients with OAB

1 March 2014 | | URO - Functional / Reconstructive Urology
This was a multinational, multicentre, randomised, double–blind, double-dummy, parallel group placebo- and active- controlled phase II study. The study enrolled 1108 men and women aged 18 and over. The criteria were: patients must have had overactive blader (OAB) symptoms for...

Medical expulsive therapy for paediatric urolithiasis

1 May 2016 | | URO - Endourology & Stones, URO - Paediatric Urology
Children who have kidney stones are likely to have recurrences. Many initial stones are treated conservatively allowing for spontaneous passage of small stones if possible. Doxazocin or tamsulosin are known to dilate the ureter and allow spontaneous passage of stones...

Vitamin B12 deficiency in patients after enterocystoplasty

1 March 2016 | | URO - Paediatric Urology
It is well known that enterocystoplasty within terminal ileum leads to vitamin B12 deficiency and regular monitoring of this post-surgery is essential. Often supplements need to be given because of deficiency in up to 40% of patients. These authors looked...

Demanding cases or nightmares in uro-oncology? Sep/Oct 2021

3 September 2021 | | URO - Urologic Oncology
Active surveillance for prostate cancer: missing the boat Case In 2005 a 43-year-old man of Afro-Caribbean ethnicity was referred to our centre for investigation of suspected prostate cancer. Digital rectal exam revealed a firm right lobe, PSA of 2.3ng/ml, prostate...

Action Bladder Cancer UK offers grants for bladder cancer research

21 November 2024 | Charities, Awards, Conferences & Anniversaries, Research & Development
Action Bladder Cancer UK (ABC UK) is inviting applications for grants to support research into bladder cancer, encouraging projects that aim to improve bladder cancer care, treatment, or diagnosis.
The BMJ cover image.

Sepsis – still a dilemma

4 March 2025 | | URO - Infection
Thousands of people die each year in the UK and worldwide due to types of sepsis, including urosepsis. Urologists are facing this scenario day in day out, so this is a vital article for every reader. We are all familiar...

Complications of CISC

1 July 2014 | | URO - Infection, URO - Functional / Reconstructive Urology, URO - Neurourology
Introduction Clean intermittent self catheterisation (CISC) was first introduced and popularised by Lapides in 1972. Since then its utilisation has become widespread and it is now commonly used throughout the world as the preferred means of facilitating complete and effective...

Suprapubic catheterisation – a core surgical trainee’s perspective

3 November 2022 | | URO - Functional / Reconstructive Urology, URO - Infection
Suprapubic catheters (SPCs) are in widespread usage in medical practice and this review will focus on the pre-assessment, indications, methods and complications that are associated with the insertion of an SPC. Although suprapubic catheter insertions may be done electively or...

Pelvic floor imaging – a brief synopsis

1 August 2016 | | URO - Uroradiology
Background Pelvic floor imaging is an important part of both gastrointestinal and functional urology / urogynaecological departments. Symptoms such as obstructive defecation, incontinence and sphincter complex disorders have a significant impact on patient lifestyle and physical / mental well-being [1,2]....

Update on immunotherapy for non-muscle invasive transitional cell carcinoma of the bladder

7 January 2021 | | URO - Urologic Oncology
Patients with high-risk non-muscle invasive bladder cancer (NMIBC) that have failed Bacillus Calmette-Guérin (BCG) treatment are a difficult group to treat, and many may not be suitable for the preferred treatment option of radical cystectomy. Bladder-preserving treatments for BCG-unresponsive high-risk...